CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
Conditions: Kidney Cancer; Renal Cell Carcinoma Interventions: Drug: Cabozantinib; Drug: Nivolumab; Procedure: Cytoreductive nephrectomy Sponsors: Mark Stein; Exelixis; Bristol-Myers Squibb Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | Kidney Cancer | Nephrectomy | Research | Urology & Nephrology